191 related articles for article (PubMed ID: 15564882)
1. Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).
Iwai M; Suzuki H; Ieiri I; Otsubo K; Sugiyama Y
Pharmacogenetics; 2004 Nov; 14(11):749-57. PubMed ID: 15564882
[TBL] [Abstract][Full Text] [Related]
2. Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.
Nozawa T; Minami H; Sugiura S; Tsuji A; Tamai I
Drug Metab Dispos; 2005 Mar; 33(3):434-9. PubMed ID: 15608127
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Plasma Membrane Localization and Phosphorylation Status of Organic Anion Transporting Polypeptide (OATP) 1B1 c.521 T>C Nonsynonymous Single-Nucleotide Polymorphism.
Crowe A; Zheng W; Miller J; Pahwa S; Alam K; Fung KM; Rubin E; Yin F; Ding K; Yue W
Pharm Res; 2019 May; 36(7):101. PubMed ID: 31093828
[TBL] [Abstract][Full Text] [Related]
4. Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
Oswald S; König J; Lütjohann D; Giessmann T; Kroemer HK; Rimmbach C; Rosskopf D; Fromm MF; Siegmund W
Pharmacogenet Genomics; 2008 Jul; 18(7):559-68. PubMed ID: 18551036
[TBL] [Abstract][Full Text] [Related]
5. Estimating In Vivo Fractional Contribution of OATP1B1 to Human Hepatic Active Uptake by Mechanistically Modeling Pharmacogenetic Data.
Li R
AAPS J; 2019 May; 21(4):69. PubMed ID: 31140055
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
7. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).
Niemi M; Schaeffeler E; Lang T; Fromm MF; Neuvonen M; Kyrklund C; Backman JT; Kerb R; Schwab M; Neuvonen PJ; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2004 Jul; 14(7):429-40. PubMed ID: 15226675
[TBL] [Abstract][Full Text] [Related]
8. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.
Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP
Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells.
Kameyama Y; Yamashita K; Kobayashi K; Hosokawa M; Chiba K
Pharmacogenet Genomics; 2005 Jul; 15(7):513-22. PubMed ID: 15970799
[TBL] [Abstract][Full Text] [Related]
10. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
11. Construction of HEK293 cells stably expressing wild-type organic anion transporting polypeptide 1B1 (OATP1B1*1a) and variant OATP1B1*1b and OATP1B1*15.
Chen M; Qu BX; Chen XL; Hu HH; Jiang HD; Yu LS; Zhou Q; Zeng S
Pharmazie; 2016 Jun; 71(6):337-9. PubMed ID: 27455553
[TBL] [Abstract][Full Text] [Related]
12. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
[TBL] [Abstract][Full Text] [Related]
13. Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1.
van de Steeg E; Greupink R; Schreurs M; Nooijen IH; Verhoeckx KC; Hanemaaijer R; Ripken D; Monshouwer M; Vlaming ML; DeGroot J; Verwei M; Russel FG; Huisman MT; Wortelboer HM
Drug Metab Dispos; 2013 Mar; 41(3):592-601. PubMed ID: 23248200
[TBL] [Abstract][Full Text] [Related]
14. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.
Maeda K; Ieiri I; Yasuda K; Fujino A; Fujiwara H; Otsubo K; Hirano M; Watanabe T; Kitamura Y; Kusuhara H; Sugiyama Y
Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.
Nishizato Y; Ieiri I; Suzuki H; Kimura M; Kawabata K; Hirota T; Takane H; Irie S; Kusuhara H; Urasaki Y; Urae A; Higuchi S; Otsubo K; Sugiyama Y
Clin Pharmacol Ther; 2003 Jun; 73(6):554-65. PubMed ID: 12811365
[TBL] [Abstract][Full Text] [Related]
16. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
17. Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.
Higgins JW; Bao JQ; Ke AB; Manro JR; Fallon JK; Smith PC; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2014 Jan; 42(1):182-92. PubMed ID: 24194513
[TBL] [Abstract][Full Text] [Related]
18. Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).
Lee HH; Ho RH
Br J Clin Pharmacol; 2017 Jun; 83(6):1176-1184. PubMed ID: 27936281
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl pharmacokinetics is not dependent on hepatic uptake by organic anion-transporting polypeptide 1B1 in human beings.
Ziesenitz VC; König SK; Mahlke N; Jantos R; Skopp G; Weiss J; Haefeli WE; Mikus G
Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):43-8. PubMed ID: 23480028
[TBL] [Abstract][Full Text] [Related]
20. Identification of Glycochenodeoxycholate 3-O-Glucuronide and Glycodeoxycholate 3-O-Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers.
Neuvonen M; Hirvensalo P; Tornio A; Rago B; West M; Lazzaro S; Mathialagan S; Varma M; Cerny MA; Costales C; Ramanathan R; Rodrigues AD; Niemi M
Clin Pharmacol Ther; 2021 Mar; 109(3):646-657. PubMed ID: 32961594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
